Preparing for success in modernizing the science behind the development and regulation of medical products
ACDRS 2022 Session 6 - Integrated Product Development, Portfolio Management, Project Management, and Preparing for Transition to the Market
Date:
Monday, October 31, 2022 - 10:00 am to Friday, November 4, 2022 - 3:00 pm
Location:
virtual/online
This is Session 6 of 6. Must register for the entire 2022 Course and not per session.
Session 6 Chairperson: Charlie Gombar, PhD, ACDRS Director
Topics
- Portfolio management: principles, challenges, and strategies
- Role of licensing in portfolio management
- Project management: principles, challenges, and strategies
- Judgment under uncertainty
- Integrated global strategy
- Turning strategy into plans
- Co-development and alliances
- Strategic marketing (commercial) role in development
- How to launch a new drug successfully into the market
- Digital transformation and artificial intelligence
- Prescription drug promotion
- Promotional committee review simulation
- Pharmacovigilance
- Leadership strategies in drug development and regulation
Lecturers
Sue Duvall, RN MPA | Principal Consultant, Duvall Limited LLC |
Charlie T. Gombar, PhD |
ACDRS Director |
Richard Heaslip, PhD |
President and Founder, Programmatic Sciences LLC |
Elaine Hughes, MBA | Bristol Myers Squibb |
Craig H. Mallinckrodt, PhD |
Senior Vice President, Statistics, Cortexyme |
Mark Noguchi, MBA | Senior Vice President and Head, Chugai Partnering, Chugai Pharmaceuticals (Japan) |
Christiane Pering, MD | Head of Medical Devices & eHealth, Bayer Pharmaceuticals |